PMID- 18411301 OWN - NLM STAT- MEDLINE DCOM- 20080708 LR - 20220309 IS - 1098-5549 (Electronic) IS - 0270-7306 (Print) IS - 0270-7306 (Linking) VI - 28 IP - 12 DP - 2008 Jun TI - The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. PG - 4104-15 LID - 10.1128/MCB.00289-08 [doi] AB - The mammalian target of rapamycin (mTOR) is a protein kinase that forms two functionally distinct complexes important for nutrient and growth factor signaling. Both complexes phosphorylate a hydrophobic motif on downstream protein kinases, which contributes to the activation of these kinases. mTOR complex 1 (mTORC1) phosphorylates S6K1, while mTORC2 phosphorylates Akt. The TSC1-TSC2 complex is a critical negative regulator of mTORC1. However, how mTORC2 is regulated and whether the TSC1-TSC2 complex is involved are unknown. We find that mTORC2 isolated from a variety of cells lacking a functional TSC1-TSC2 complex is impaired in its kinase activity toward Akt. Importantly, the defect in mTORC2 activity in these cells can be separated from effects on mTORC1 signaling and known feedback mechanisms affecting insulin receptor substrate-1 and phosphatidylinositol 3-kinase. Our data also suggest that the TSC1-TSC2 complex positively regulates mTORC2 in a manner independent of its GTPase-activating protein activity toward Rheb. Finally, we find that the TSC1-TSC2 complex can physically associate with mTORC2 but not mTORC1. These data demonstrate that the TSC1-TSC2 complex inhibits mTORC1 and activates mTORC2, which through different mechanisms promotes Akt activation. FAU - Huang, Jingxiang AU - Huang J AD - Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, USA. FAU - Dibble, Christian C AU - Dibble CC FAU - Matsuzaki, Mika AU - Matsuzaki M FAU - Manning, Brendan D AU - Manning BD LA - eng GR - P01 CA120964/CA/NCI NIH HHS/United States GR - T32 ES07155/ES/NIEHS NIH HHS/United States GR - R01 CA122617/CA/NCI NIH HHS/United States GR - R01-CA122617/CA/NCI NIH HHS/United States GR - P01-CA120964/CA/NCI NIH HHS/United States GR - T32 ES007155/ES/NIEHS NIH HHS/United States GR - R01 CA122617-03/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20080414 PL - United States TA - Mol Cell Biol JT - Molecular and cellular biology JID - 8109087 RN - 0 (Multiprotein Complexes) RN - 0 (Proteins) RN - 0 (TSC1 protein, human) RN - 0 (TSC2 protein, human) RN - 0 (Transcription Factors) RN - 0 (Tsc1 protein, mouse) RN - 0 (Tsc2 protein, mouse) RN - 0 (Tuberous Sclerosis Complex 1 Protein) RN - 0 (Tuberous Sclerosis Complex 2 Protein) RN - 0 (Tumor Suppressor Proteins) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Animals MH - Cell Line MH - Cell Line, Tumor MH - Fibroblasts/metabolism MH - *Gene Expression Regulation MH - HeLa Cells MH - Humans MH - Mechanistic Target of Rapamycin Complex 1 MH - Mice MH - Models, Biological MH - Multiprotein Complexes MH - Protein Kinases/*metabolism MH - Proteins MH - Proto-Oncogene Proteins c-akt/metabolism MH - TOR Serine-Threonine Kinases MH - Transcription Factors/*metabolism MH - Tuberous Sclerosis Complex 1 Protein MH - Tuberous Sclerosis Complex 2 Protein MH - Tumor Suppressor Proteins/metabolism/*physiology PMC - PMC2423120 EDAT- 2008/04/16 09:00 MHDA- 2008/07/09 09:00 PMCR- 2008/10/01 CRDT- 2008/04/16 09:00 PHST- 2008/04/16 09:00 [pubmed] PHST- 2008/07/09 09:00 [medline] PHST- 2008/04/16 09:00 [entrez] PHST- 2008/10/01 00:00 [pmc-release] AID - MCB.00289-08 [pii] AID - 0289-08 [pii] AID - 10.1128/MCB.00289-08 [doi] PST - ppublish SO - Mol Cell Biol. 2008 Jun;28(12):4104-15. doi: 10.1128/MCB.00289-08. Epub 2008 Apr 14.